| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 63.0236 | 66 |
| GSM780708 | Untreated after 4 days (C2_1) | 63.6594 | 67 |
| GSM780709 | Untreated after 4 days (C3_1) | 50.3481 | 50 |
| GSM780719 | Untreated after 4 days (C1_2) | 59.9678 | 64 |
| GSM780720 | Untreated after 4 days (C2_2) | 58.4259 | 63 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.1168 | 45 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 84.0864 | 73 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 54.4971 | 59 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 121.981 | 78 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 86.9418 | 73 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 55.0644 | 60 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 116.631 | 77 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 47.0222 | 37 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 73.7143 | 70 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 57.0718 | 62 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.5522 | 30 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 73.5527 | 70 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 56.7891 | 62 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 63.3015 | 66 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 56.9455 | 62 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 63.9785 | 67 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 52.0464 | 54 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 59.5642 | 64 |